山西医科大学学报2011，Vol.42Issue(11)：905-907,3.DOI:10.3969/J.ISSN.1007-6611.2011.11.013
黛力新联合埃索美拉唑治疗非糜烂性胃食管反流病的疗效观察
Study on the effect of deanxit combined with esomeprazole in the treatment of non-erosive gastroesophageal reflux disease
任素芳 1邱服斌2
作者信息
- 1. 山西医科大学公共卫生学院,太原,030001
- 2. 山西省太原市中心医院消化科
- 折叠
摘要
Abstract
Objective To explore the clinical efficacy of deanxit combined with esomeprazole in the treatment of non-erosive reflux disease. Methods Sixty patients with non-erosive gastroesophogeal reflux disease were divided into treatment group and control group. The patients in treatment group were orally administrated with esomprazloe 20 mg once a day,deanxit 10. 5 mg once a day, and domperidone 10 mg three times a day. The patients in control group were orally administrated with esomprazole 20 mg once a day, and domperidone 10 mg three times a day. Results After treatment for 8 weeks, the symptoms of acid reflux, heartburn, chest pain in two groups were improved. The effective rate was significantly higher in treatment group than in control group( 96. 67% vs 73. 33% , P＜ 0. 05 ). Conclusion Deanxit combined with esomeprazole are more effective for treating non-erosive gastroesophageal reflux disease than the equal dose of omeprazole.关键词
非糜烂性胃食管反流病/埃索美拉唑/黛力新Key words
non-erosive gastroesophageal reflux disease/esomeprazole/deanxit分类
医药卫生引用本文复制引用
任素芳,邱服斌..黛力新联合埃索美拉唑治疗非糜烂性胃食管反流病的疗效观察[J].山西医科大学学报,2011,42(11):905-907,3.
